Daily Sepsis Research Analysis
Three studies advance sepsis precision: a prospective cohort shows that a macrophage activation-like syndrome subphenotype (via ferritin and mHLA-DR) independently predicts in-hospital mortality; a secondary prospective analysis finds monocyte distribution width reliably distinguishes sepsis from sterile inflammation in surgical/trauma ICU patients; and a proof-of-principle post hoc analysis demonstrates early non-invasive photoplethysmography can identify patients likely to need vasopressors, s
Summary
Three studies advance sepsis precision: a prospective cohort shows that a macrophage activation-like syndrome subphenotype (via ferritin and mHLA-DR) independently predicts in-hospital mortality; a secondary prospective analysis finds monocyte distribution width reliably distinguishes sepsis from sterile inflammation in surgical/trauma ICU patients; and a proof-of-principle post hoc analysis demonstrates early non-invasive photoplethysmography can identify patients likely to need vasopressors, supporting personalized resuscitation.
Research Themes
- Immune subphenotyping to predict mortality in sepsis
- Point-of-care hematology biomarkers for sepsis diagnosis in surgical/trauma ICU
- Non-invasive physiologic monitoring to guide personalized hemodynamic resuscitation
Selected Articles
1. Immune Response Subphenotyping to Predict Mortality in Sepsis: A Prospective Study in Resource-Limited Setting.
In a prospective cohort of 200 adults with sepsis, classifying patients using ferritin (>4420 ng/mL) and mHLA-DR defined a MALS subphenotype with markedly higher in-hospital mortality. After adjustment, MALS remained an independent predictor of death (HR 1.7), suggesting pragmatic immune subphenotyping can refine early risk stratification in resource-limited settings.
Impact: Demonstrates that a parsimonious, biologically grounded immune subphenotype (MALS) robustly predicts mortality, enabling pragmatic prognostic enrichment where advanced resources are limited.
Clinical Implications: Ferritin-based screening for MALS at admission can flag extremely high-risk patients for closer monitoring, early escalation, and stratified enrollment in immunomodulatory trials; feasibility may be enhanced by prioritizing ferritin where mHLA-DR assays are unavailable.
Key Findings
- Using ferritin >4420 ng/mL defined MALS in 27% (54/200) of patients; 9.5% had immunoparalysis (low mHLA-DR with non-elevated ferritin).
- In-hospital mortality was 83.3% (MALS), 68.4% (immunoparalysis), and 51.1% (unclassified).
- MALS independently predicted mortality after adjustment (HR 1.7; 95% CI 1.13–2.49; p=0.01), whereas immunoparalysis did not show proportional hazards versus unclassified.
Methodological Strengths
- Prospective cohort design across ED, wards, and ICU with predefined immune thresholds
- Adjusted survival analysis with assessment of proportional hazards
Limitations
- Single-center study; generalizability requires external validation
- mHLA-DR measurement may be resource-intensive in low-resource settings; substantial unclassified group
Future Directions: Validate ferritin-driven MALS stratification across diverse settings; test tailored immunomodulatory strategies (e.g., anti-cytokine approaches) in MALS-enriched randomized trials; assess simplified algorithms omitting mHLA-DR.
IMPORTANCE: Sepsis remains a leading cause of death in infectious cases. The heterogeneity of immune responses is a major challenge in the management and prognostication of patients with sepsis. Identifying distinct immune response subphenotypes using parsimonious classifiers may improve outcome prediction, particularly in resource-limited settings. OBJECTIVES: This study aimed to evaluate whether classification of the immune response can serve as a predictor of mortality. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted in the emergency department, inpatient wards, and ICU of a tertiary hospital. Adult patients diagnosed with sepsis within the previous 24 hours were included. Exclusion criteria were history of RBC transfusion, major thalassemia, decompensated cirrhosis, hematologic malignancy, or use of immunosuppressive or chronic corticosteroid therapy. Demographic, clinical, and laboratory data-including serum ferritin and monocyte human leukocyte antigen-DR/Human Leukocyte Antigen-DR) (mHLA-DR) levels-were collected. MAIN OUTCOMES AND MEASURES: Subjects were classified into the following immune subphenotypes: macrophage activation-like syndrome (MALS) (if ferritin > 4420 ng/mL), immunoparalysis (if mHLA-DR < 10,000 receptors/cell and ferritin ≤ 4420 ng/mL), and unclassified (if they did not meet the criteria for either MALS or immunoparalysis). The primary outcome was in-hospital mortality. RESULTS: Of the 200 subjects recruited, 54 (27%) were classified into the MALS group, 19 (9.5%) into the immunoparalysis group, and the remainder into the unclassified group. The in-hospital mortality rates for the MALS, immune paralysis, and unclassified groups were 83.3%, 68.4%, and 51.1%, respectively. The proportional hazards assumption was met between the MALS and unclassified groups (crude hazard ratio [HR] 2.3; 95% CI, 1.56-3.35) but not between the immunoparalysis and unclassified groups (crude HR 1.4; 95% CI, 0.76-2.50). After adjusting for confounding variables, MALS's adjusted HR was 1.7 (95% CI, 1.13-2.49; p = 0.01). CONCLUSIONS AND RELEVANCE: The MALS subphenotype is an independent predictor of in-hospital mortality in sepsis.
2. A Novel Approach to Early Personalized Hemodynamic Resuscitation: Non-Invasive Peripheral Photoplethysmography for Identifying Predominant Vasodilatory Shock in Sepsis.
Using early peripheral PPG signals and unsupervised profiling, researchers identified physiologic components and predicted need for vasopressors (AUROC 0.75), improving to 0.83 when combined with MAP and lactate. This supports rapid, non-invasive phenotyping of vasodilatory shock at ED arrival to guide individualized resuscitation.
Impact: Introduces a non-invasive, rapid physiologic tool to phenotype hemodynamic shock mechanisms in sepsis at the bedside, potentially reducing harms from uniform fluid resuscitation.
Clinical Implications: PPG-based early profiling could identify patients with predominant vasodilation who may benefit from earlier vasopressors and conservative fluids, pending prospective validation and clinical workflow integration.
Key Findings
- Among 325 ED patients with suspected infection and hemodynamic instability, 16.3% required vasopressors within 24 hours.
- PPG-derived PCA identified three physiologic components (arterial compliance; cardiac output/systemic vascular resistance; peripheral vasomotor tone) explaining 80.3% of variance.
- PPG-based prediction of vasopressor initiation achieved AUROC 0.75, improving to 0.83 with MAP and lactate.
Methodological Strengths
- Use of real-world biobank with standardized early PPG capture and outcome ascertainment
- Physiology-informed dimensionality reduction (PCA) with interpretable components
Limitations
- Post hoc, single-center observational analysis; no prospective or interventional validation
- Potential confounding and signal quality variability in ED environment
Future Directions: Prospectively validate PPG-guided resuscitation algorithms and test randomized strategies (early vasopressors vs fluid-first) in PPG-defined vasodilatory phenotypes.
INTRODUCTION: Sepsis remains a leading cause of mortality, with mortality from septic shock exceeding 40%. Standardized resuscitation (30 mL/kg) may cause adverse outcomes, including fluid overload or prolonged hypotension, emphasizing the need for individualized strategies. Sepsis-induced shock arises from varying degrees of vasodilation and hypovolemia, yet patients often present with similar clinical signs in the emergency department (ED). Photoplethysmography (PPG), a non-invasive technique reflecting peripheral perfusion, may help identify patients with a predominant vasodilatory profile who could benefit from early vasopressor therapy. METHODS: This post hoc analysis used data from the Acutelines biobank at the University Medical Centre Groningen. Adults admitted for non-trauma specialties with suspected infection and hemodynamic instability (MAP < 70 mmHg, SBP < 90 mmHg, shock index > 0.9, or lactate > 4.0 mmol/L) were included. PPG data were pre-processed and features extracted. Principal component analysis (PCA) and K-means clustering enabled dimensionality reduction and hemodynamic profiling. Logistic regression assessed the discriminative performance of PPG-based models for vasopressor therapy initiation within 24 h. RESULTS: Among 325 patients, 16.3% received vasopressors. PCA identified three principal components explaining 80.3% of variance: PC1 (arterial compliance), PC2 (cardiac output and systemic vascular resistance), and PC3 (peripheral vasomotor tone). The PPG-based model showed moderate discriminative power (AUROC: 0.75), improving when combined with MAP and lactate (AUROC: 0.83). CONCLUSION: PPG enables identification of patients likely to benefit from vasopressor therapy during the first 20 min after ED arrival. By providing additional insight into peripheral perfusion, this proof-of-principle study supports further exploration of PPG as a clinical support tool for personalized hemodynamic resuscitation in sepsis. EDITORIAL COMMENT: This secondary analysis demonstrates early peripheral circulatory patterns in sepsis using photoplethysmography at the start of resuscitation. Distinct PPG-derived profiles were associated with vasopressor initiation within 24 h, supporting PPG as a tool for personalized resuscitation.
3. Monocyte Anisocytosis Can Discriminate Between Sepsis and Sterile Inflammation, but not Mortality, in Critically Ill Surgical/Trauma Patients: A Secondary Prospective Analysis.
In 238 surgical/trauma ICU patients, MDW at ICU admission distinguished sepsis from nonseptic critical illness with AUROC 0.85 and a cutoff >22.0 yielding 90% sensitivity and 78% specificity. However, MDW did not predict in-hospital, 30-day, or 90-day mortality.
Impact: Supports an accessible hematology parameter (MDW) as a robust diagnostic aid to distinguish sepsis from sterile inflammation specifically in surgical/trauma ICUs, addressing a difficult diagnostic gap.
Clinical Implications: ICU admission MDW could serve as a rapid adjunct to clinical assessment to trigger early sepsis pathways in surgical/trauma patients, while other markers or scores remain necessary for mortality risk stratification.
Key Findings
- MDW was significantly higher in sepsis vs critically ill nonseptic patients at ICU admission (median 26.4 [IQR 23.5–30.8] vs 20.1 [IQR 17.9–21.9]; p<0.001).
- Diagnostic performance for sepsis: AUROC 0.85 (95% CI 0.79–0.91); cutoff >22.0 yielded 90% sensitivity and 78% specificity.
- MDW did not discriminate in-hospital, 30-day, or 90-day mortality.
Methodological Strengths
- Secondary analysis of prospectively collected cohorts with adjudicated diagnoses
- Serial sampling during ICU stay enabling temporal assessment
Limitations
- Single-center sample with modest size; generalizability limited
- No direct comparison with other biomarkers (procalcitonin, CRP, IL-6); missing data imputation assumptions
Future Directions: Head-to-head comparisons of MDW with established biomarkers and integration into multivariable diagnostic algorithms; multicenter validation in surgical ICUs.
OBJECTIVES BACKGROUND: Monocyte anisocytosis (monocyte distribution width [MDW]) has been previously validated to predict sepsis and outcome in patients presenting in the emergency department and mixed-population ICUs. Determining sepsis in a critically ill surgical/trauma population is often difficult due to concomitant inflammation and stress. We examined whether MDW could identify sepsis among patients admitted to a surgical/trauma ICU and predict clinical outcome. DESIGN: Secondary analysis of three prospective observational clinical studies. SETTING: Single institution ICU. PATIENTS/SUBJECTS: Two hundred thirty-eight participants were included in this study: 107 patients who were admitted to the ICU and adjudicated to have sepsis, 80 patients who were considered critically ill nonseptic (CINS), and 51 healthy control participants. INTERVENTIONS: MDW was measured among hospitalized patients admitted to the ICU with the diagnosis of sepsis or CINS patients at risk of developing sepsis. Blood samples were collected at admission and at intervals during ICU admission. MEASUREMENTS AND MAIN RESULTS: MDW significantly differed between septic and CINS patients on ICU admission (26.4, interquartile range [IQR, 23.5-30.8] vs. 20.1 [IQR, 17.9-21.9]; p < 0.001) and could discriminate with an area under the receiver operating characteristic curve of 0.85 (95% CI, 0.79-0.91; p < 0.001). An MDW of greater than 22.0 at admission to the ICU could identify sepsis with a 78% specificity and a 90% sensitivity but could not discriminate in-hospital, 30-day, or 90-day mortality. LIMITATIONS: Small sample size from a single institution. Our analysis did not include other relevant biomarkers such as procalcitonin, C-reactive protein, and interleukin-6. In the imputation of missing values, linear mixed-effect models were used, risking model misspecification and the violation of the missing-at-random assumption. CONCLUSIONS: Among surgical/trauma ICU patients, MDW can discriminate between sepsis and nonseptic inflammation, but it is a weak predictor of mortality.